Phase III QUARTZ study of QMF-149 in inadequately controlled asthma meets primary endpoint May 30, 2019
Mereo reports 6-month open-label data from phase IIb study of BPS-804 in osteogenesis imperfecta May 30, 2019
Michael J. Fox Foundation awards Casma Therapeutics grant to advance PD drug development May 30, 2019
Phase III KALM-1 study of Korsuva in hemodialysis patients with pruritus meets primary endpoint May 30, 2019
RSS